Neurocrine Biosciences (NBIX) Fair Value & DCF

NBIX$171.80+2.66 +1.57%
BiotechnologyLarge CapGrowth StockHigh Quality
Compare
Market cap$17.39BEnterprise value$16.56BRevenue (TTM)$3.70BMarket positionTop 25%

Score

67
Bullish
Value
46
Quality
70
Growth
85

Neurocrine Biosciences, Inc. (NBIX) trades at $171.80 on $17.39B of equity value, with a trailing P/E of 24.37. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.

Neurocrine Biosciences (NBIX) Fair Value & DCF

NBIX price $171.80 +2.66 +1.57%

Ticker
NBIX
Price
$171.80
Change
+2.66 +1.57%
Market cap
$17.39B
P/E
24.37
Forward P/E
18.66
Dividend yield
0.00%
Beta
0.36
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
67
Value
46
Quality
70
Growth
85

Stocklytics score rationale: value 46, quality 70, growth 85.

AI Score 85. Neurocrine Biosciences, Inc. has a strong market cap of $16.76 billion and impressive profit margins, including a net profit margin of 18.98%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener